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Abstract
Background: Staphylococcal enterotoxins (SEs), SE-like (SEl) toxins, and toxic shock syndrome toxin-1 (TSST-1),
produced by Staphylococcus aureus, belong to the subgroup of microbial superantigens (SAgs). SAgs induce clonal
proliferation of T cells bearing specific variable regions of the T cell receptor b chain (Vb). Quantitative real time
PCR (qRT-PCR) has become widely accepted for rapid and reproducible mRNA quantification. Although the
quantification of Vb subgroups using qRT-PCR has been reported, qRT-PCR using both primers annealing to
selected Vb nucleotide sequences and SYBR Green I reporter has not been applied to assess Vb-dependent
expansion of T cells by SAgs.
Methods: Human peripheral blood mononuclear cells were stimulated with various SAgs or a monoclonal
antibody specific to human CD3. Highly specific expansion of Vb subgroups was assessed by qRT-PCR using SYBR
Green I reporter and primers corresponding to selected Vb nucleotide sequences.
Results: qRT-PCR specificities were confirmed by sequencing amplified PCR products and melting curve analysis.
To assess qRT-PCR efficiencies, standard curves were generated for each primer set. The average slope and R
2 of
standard curves were -3.3764 ± 0.0245 and 0.99856 ± 0.000478, respectively, demonstrating that the qRT-PCR
established in this study is highly efficient. With some exceptions, SAg Vb specificities observed in this study were
similar to those reported in previous studies.
Conclusions: The qRT-PCR method established in this study produced an accurate and reproducible assessment of
Vb-dependent expansion of human T cells by staphylococcal SAgs. This method could be a useful tool in the
characterization T cell proliferation by newly discovered SAg and in the investigation of biological effects of SAgs
linked to pathogenesis.
Background
The a/b T cell receptor (TCR) is composed of a and b
chain heterodimers which recognize antigen-derived
peptide bound to major histocompatibility complex
(MHC) molecules on antigen presenting cells (APCs)
[1]. During thymocyte development, the genes encoding
the b chain undergo somatic recombination of variable
(V), diversity (D), joining (J), and constant (C) genes.
Combinatorial joining of V-J and V-D-J region gene seg-
ments generates diversity within the TCR b chain com-
plementarity determining region (CDR) 3 loop [2,3].
Combinatorial diversity is further increased by imprecise
joining of VDJ recombination and insertion of palindro-
mic nucleotides at a specific point within the VD, DJ,
and VJ junctions [4]. As a result, each T cell clone
expresses a unique variable region of TCR b chain (Vb)
[5]. Generally, the CDR1 and CDR2 sequences within
the TCR molecule, encoded by V gene segments, inter-
act with the a helix of the MHC molecule [6]. TCR
CDR3 sequences, encoded by V(D)J junction gene seg-
ments, interact with the antigenic peptide associated
with MHC, resulting in clonal T cell proliferation [6].
Staphylococcal enterotoxins (SEs), SE-like (SEl) toxins
and toxic shock syndrome toxin-1 (TSST-1), produced
by Staphylococcus aureus, are prototypic microbial
superantigens (SAgs). Members of this toxin subgroup
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toxic shock syndrome [7]. SEl toxins have been shown
to lack emetic properties in primates or have not yet
been tested [8]. For many years, five antigenically dis-
tinct classic SEs (SEA, SEB, SEC, SED, and SEE) and
molecular variants of SEC (SEC1, SEC2, and SEC3) were
recognized [7]. Through improvements in genomic ana-
l y s i st o o l s ,n o v e lS E sa n dS E lt o x i n si n c l u d i n gS E G ,
SElH, SEI, SElJ, SElK, SElL, SElM, SElO, SElP, SElQ,
SElR, and SElU and four molecular variants (SEGv,
SEIv, SElNv, and SElUv) have been discovered [7,9]. In
contrast to conventional ant i g e n s ,m o s tS A g sb i n do u t -
side the peptide binding groove of MHC II, and to spe-
cific Vb sequences [9]. This interaction triggers an
activation of phospholipase C and phosphokinase C
pathways [10], leading to a massive production of proin-
flammatory cytokines including interleukin-2 and inter-
feron-g [11], resulting in extensive proliferation of T
cells bearing specific Vb s u b g r o u p s[ 1 1 ] .A sar e s u l t ,i t
is possible to characterize SAgs on the basis of their Vb
profiles [7].
Several approaches are used to quantify the expansion
of Vb subgroups including northern blotting, semi-
quantitative PCR using radioisotope conjugated probes
[12], or fluorescence activated cell sorting (FACS) using
monoclonal antibodies (mAbs) specific to Vb subgroups
[13,14]. Recently, quantitative real time PCR (qRT-PCR)
has become widely accepted for rapid and reproducible
quantification of gene expression. Most previous
attempts to quantify Vb expression using qRT-PCR
used one primer located at the gene encoding TCR con-
stant region of b chain (Cb) and the other primer or
fluorogenic probe located within the gene encoding the
V region [15,16]. More importantly, previous qRT-PCR
methods have been applied to samples displaying expan-
sion of limited numbers of Vb subgroups [16]. In this
study, we developed a new qRT-PCR method using Vb
subgroup specific primers within the gene encoding the
V region to increase specificity and SYBR Green I to
curtail the cost of the assay. This technique was applied
to human mononuclear cell cultures stimulated with
various SAgs, which have unique Vb specificities,
though overlapping so that the entire repertoire of Vb
subgroups could be evaluated using this method.
Materials and methods
Toxin production and purification
SEB, SEC1 and TSST-1 were purified from cultures of S.
aureus MNHOCH, S. aureus RN4220 (pMIN121) and S.
aureus RN4220 (pCE107), respectively, using preparative
isoelectric focusing as described previously [17-19].
Other toxins used in this study were produced in
recombinant form using SE genes cloned in this study
as follows. A DNA fragment encoding SEA, SED, SEE,
SEG, SEI, SElM, SElN, or SElO was amplified from
genomic DNA derived from S. aureus FRI 913 or FRI
472 using primers listed in Table 1[20]. Amplified DNA
fragments were digested with NdeI and BamHI or XhoI
and ligated into corresponding sites is pET-15b (Nova-
gen, San Diego, California, USA). Recombinant SE pro-
teins were expressed in E. coli BL21 (DE3) (pLysS) and
purified using the His-Bind Purification Kit (Novagen)
as suggested by the manufacturer.
Preparation and stimulation of enriched human
lymphocytes
Peripheral blood mononuclear cells (PBMCs) were iso-
lated from three healthy donor venous blood. Heparin-
treated (14 U/ml blood) blood was fractionated by gradi-
ent centrifugation over Ficoll-Paque Plus (GE Health-
care, Piscataway, New jersey, USA) as described
previously [17]. The PBMCs were washed and resus-
pended in RPMI 1640 medium (Life technologies,
Gaithersburg, Maryland, USA) supplemented with 2%
FBS, 100 U penicillin G, and 100 μg/ml streptomycin.
The cultures were maintained in cell culture Petri dishes
(Falcon, Lincoln Park, New Jersey) overnight at 37°C
and in 5% CO2. Non-adherent lymphocyte-enriched
PBMCs were collected, washed, and resuspended at a
final concentration of 2.5 × 10
6 cells/ml. Each SAg (0.5
μg/ml) or a murine mAb specific to human CD3 (33
ng/ml; Sigma, St. Louis, Missouri, USA) was added to
lymphocyte enriched PBMC cultures (3 ml aliquots).
Cultures were maintained for 4 days (37°C, 5% CO2).
Table 1 List of primers used to clone SE and SEl genes.
SE name GenBank access number Forward primer (’5t o3 ’) Reverse primer (’5t o3 ’)
SEA M18970 cttgtacatatgagcgagaaaagcgaagaa gcgcggatccttaacttgtatataaata
SED M28521 cgttctcgagaatgaaaacattgattc cgcgctcgagctacttttcatataaata
SEE M21319 ggtagccatatgagcgaagaaataaatgaa gcgcggatcctcaagttgtgtataaata
SEG AF064773 tgtgcatatgcaacccgatcctaaatta gcgcggatcctcagtgagtattaaga
SEI AF285760 tgctctcgaggatattggtgtaggtaac cgcgctcgagttagttactatctacata
SElM AF285760 cgcacatatggatgtcggagttttgaat gcgcggatcctcaactttcgtccttata
SElN AF285760 aatgctcatatggacaaaaaagatttaaag gcgcggatccttaatctttatataaaa
SElO AF285760 tgcactcgagaatgaagaagatcctaaa cgcgctcgagttatgtaaataaataaac
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mulated control cultures.
Quantitative RT-PCR (qRT-PCR)
Total RNA was extracted from approximately 5 × 10
6
cells using Trizol (Life Technologies). Superscript II
reverse transcriptase (Life Technologies) was used to
generate cDNA using 1 μg of RNA and oligo dT primer,
according to the manufacturer’s instructions. To pro-
mote highly specific amplification, two primers specific
for each of the various Vb subgroups were annealed to
selected Vb nucleotide sequences. All Vb specific and
Cb primers were designed using Primer Express version
2.0 (Applied Biosystems, Foster City, California, USA)
and are listed in Table 2. We used the Vb subgroup
nomenclature of Arden et al [21].
To verify primer specificities, melting curve analyses
(below) and PCR product sequencing were performed.
For sequencing, PCR reactions were conducted without
SYBR Green I using cDNA generated from cultures sti-
mulated CD3-specific mAb. PCR products were purified
using a PCR purification kit (Qiagen, Valencia, Califor-
nia, USA) and then cloned into pCR2.1 vector (Life
Technologies). Transformants (10 to 25 colonies) were
randomly selected and the cloned gene fragments were
sequenced using an ABI Prism 3100 Genetic Analyzer
(Applied Biosystems).
Standard curves were generated for each gene to eval-
uate primer efficiency and for data analysis. Concentra-
tions of purified PCR products were determined by
measuring the absorbance at 260 nm using a Nanodrop
(Thermo Scientific, Wilmington, Delaware, USA) and
expressed as the number of DNA copies/ml using stan-
dard procedures [22,23]. The qRT-PCR was performed
(below) on serially diluted PCR products (2.5 - 2.5 × 10
5
copies/reaction) using ABI Prism 7500 (Applied Biosys-
tems) in triplicate and was repeated in at least three
separate experiments. Standard curves were generated
by plotting the CT vs. the log10
copies of serially diluted
PCR products. The slope, intercept, and correlation
coefficient (R
2) were determined by linear regression
analysis using Microcal OriginPro Version 7.5 (Origi-
nLab, Northampton, Massachusetts, USA).
The qRT-PCR was performed in triplicate and was
repeated in at least three separate experiments using
the following conditions. Reaction mixtures contained
12.5 μl of SYBR Green I dye master mix (Applied Bio-
systems), 2 pmoles each of forward and reverse
Table 2 List of qRT-PCR primersa and amplified Vb gene(s).
Primer name GenBank access number Forward primer (’5t o3 ’) Reverse primer (’5t o3 ’) Amplified Vb gene(s)
b
Cb L36092 tccagttctacgggctctcg gacgatctgggtgacgggt
VB1 L36092 ggagcaggcccagtggat cgctgtccagttgctggtat TCRVB1s1
VB2 M11955 gagtctcatgctgatggcaact tctcgacgccttgctcgtat TCRVB2s1
VB3 U08314 tcctctgtcgtgtggccttt tctcgagctctgggttactttca TCRVB3s1
VB4 L36092 ggctctgaggccacatatgag ttaggtttgggcggctgat TCRVB4s1
VB5 L36092 gctccaggctgctctgttg tttgagtgactccagcctttactg TCRVB5s1, 5s3
VB6 X61440 ggcagggcccagagtttc gggcagccctgagtcatct TCRVB6s1, 6s2, 6s3, 6s4, 6s5, 6s6
VB7 U07977 aagtgtgccaagtcgcttctc tgcagggcgtgtaggtgaa TCRVB7s1, 7s2, 7s3
VB8 X07192 tgcccgaggatcgattctc tctgagggctggatcttcaga TCRVB8s1, 8s2, 8s3
VB9 U07977 tgcccgaggatcgattctc tctgagggctggatcttcaga TCRVB9s1
VB11 L36092 catctaccagaccccaagatacct atggcccatggtttgagaac TCRVB11s1
VB12 U03115 gttcttctatgtggccctttgtct tcttgggctctgggtgattc TCRVB12s1, 12s3
VB13A L36092 tggtgctggtatcactgaccaa ggaaatcctctgtggttgatctg TCRVB13s1, 13s6
VB13B X61445 tgtgggcaggtccagtga tgtcttcaggacccggaatt TCRVB13s2, 13s9
VB14 L36092 gctccttggctatgtggtcc ttgggttctgggtcacttgg TCRVB14s1
VB15 M11951 tgttacccagaccccaagga tgacccttagtctgagaacattcca TCRVB15s1
VB16 X06154 cggtatgcccaacaatcgat caggctgcaccttcagagtaga TCRVB16s1
VB17 U48260 caaccaggtgctctgctgtgt gactgagtgattccaccatcca TCRVB17s1
VB18 L36092 ggaatgccaaaggaacgattt tgctggatcctcaggatgct TCRVB18s1
VB20 L36092 aggtgccccagaatctctca ggagcttcttagaactcaggatgaa TCRVB20s1
VB21 M33233 gctgtggctttttggtgtga caggatctgccggtaccagta TCRVB21s1
VB22 L36092 tgaaagcaggactcacagaacct tcacttcctgtcccatctgtgt TCRVB22s1
VB23 U03115 ttcagtggctgctggagtca cagagtggctgtttccctcttt TCRVB23s1
VB24 U03115 acccctgataacttccaatcca cctggtgagcggatgtcaa TCRVB24s1
aThe pseudogenes (Vb10 and Vb19) were not included in this study.
bVb subgroup nomenclature followed the classification of Arden et al. [21].
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cycle conditions included initial denaturation at 50°C
and 95°C (10 min each), followed by 40 cycles at 95°C
(15 s) and 60°C (1 min). Fluorescent data were
acquired during each extension phase. After 40 cycles,
a melting curve was generated by slowly increasing
(0.1°C/s) the temperature from 60°C to 95°C, while the
fluorescence was measured. The threshold cycle (CT)
was calculated using the Sequence Detector Systems
version 1.2.2 (Applied Biosystems) by determining the
cycle number at which the change in the fluorescence
of the reporter dye (ΔRn) crossed the threshold. To
synchronize each experiment, the baseline was set
automatically by the software. To rule out DNA con-
tamination in the RNA preparations, the qRT-PCR
controls were performed with RNA templates which
did not show any amplification.
Data analysis
Calculations to determine the extent of Vb expansion
were done as described by calculating the absolute copy
number of each Vb and Cb.B r i e f l y ,t h eC T for each Vb
and Cb was converted into absolute copy number by
extrapolation from its standard curve (above). The per-
centage of each Vb (%Vb) in the culture was calculated
by following equation, where n represents each Vb sub-
group observed in this study. These values have to be
considered as exploratory:
%V
V n
C
n 








100
Selective expansion of Vbs in the culture stimulated
with SAgs was determined when each %Vb from the
cultures stimulated with SAgs was significantly higher
than the corresponding %Vb from the control cultures
(without stimuli) by paired t-test (p < 0.001) using SAS
statistical software (version 9.0, SAS Institute Inc., Cary,
North Carolina, USA).
Results
Sensitivity and efficiency of the qRT-PCR
cDNA was generated from cultures stimulated with a
CD3-specific mAb, amplified by PCR using primers spe-
cific for Vb,C b,a n dG 3 P D Hg e n e s .S t a n d a r dc u r v e s
were generated using the purified PCR products. Repre-
s e n t a t i v er e s u l t sf r o maC b primer-based reaction are
shown in Figure 1A. The qRT-PCR could detect ≤25
copies of Cb PCR products without detectable variation
among triplicate reactions (Figure 1A). The slope and
correlation coefficient (R
2) of standard curves are used
to determine primer efficiency and standard curve valid-
ity, respectively. Results obtained with the Cb reaction
are representative data showing the slope for Cb
reaction was -3.38 with R
2 value of 0.9986 (Figure 1B).
The slope and R
2 value of standard curves for other
reactions are listed in Table 3.
Specificity of the qRT-PCR
qRT-PCR specificities were assessed by melting curve
analysis and sequencing of amplified PCR products.
Melting curves of the qRT-PCR reactions observed for
Vb subgroups consisting of a single gene, as well as
G3PDH and Cb genes, showed single peak. A represen-
tative result obtained for Vb1i ss h o w ni nF i g u r e1 C .
The melting curve for the Vb1 reaction contained a sin-
gle peak at 78°C. Melting curves for Vb subgroups con-
sisting of multiple subgroup genes (Vb7, 12, 13A, and
17) showed multiple peaks due to the expected hetero-
geneity in amplified gene fragments. Representative
results for Vb17 are shown in Figure 1D. qRT-PCR for
Vb17, which contains three subgroup genes produced a
melting curve with three peaks as expected. However,
some Vb subgroups consisting of multiple subgroup
genes (Vb5, 6, 8, 13B, and 21) showed only a single
peak (data not shown). To identify whether primers
designed for these Vb subgroups amplified the targeted
subgroup genes, PCR products were cloned and
sequenced. This revealed that, except for Vb21, the pri-
mers amplified multiple Vb subgroup genes within the
targeted Vb subgroup (Table 2). No untargeted
sequences were generated. We also analyzed the ampli-
fied PCR products using agarose gel electrophoresis and
confirmed that there was no non-specific amplification
other than expected size of amplification product (data
not shown).
Quantification of Vb expansion
To assess the basal expression level, the percentage of
each Vb (%Vb) in cultures without stimuli was calcu-
lated (Figure 2; unstimulated panel). Similarly, the
expression of each Vb subgroup gene was determined
for cultures stimulated with anti-CD3 mAb or various
SAgs. Selective expansion of T cells bearing certain Vb
subgroups was considered to be significant when the %
Vb in the stimulated cultures was elevated at a statisti-
cally significant level (p < 0.05). There was no significant
difference among levels observed in cultures stimulated
with the anti-CD3 mAb and unstimulated cultures (Fig-
ure 2). In contrast, the pattern of Vb expression in cul-
tures stimulated with various SAgs showed a distinct
expansion of T cells bearing certain Vb subgroups (Fig-
u r e s3 ,T a b l e4 ) .T h ed a t ai n d i c a t et h a te a c hV b sub-
group was expanded by one or more SAgs used in this
study. As shown in Table 4, the Vb specificities of SAgs
observed in this study were very similar to those
described in previous studies with minor variation as
discussed below [7,11,12,24-26].
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More than 67 different human Vb genes, of which a
quarter are pseudogenes, have been have been cloned
and sequenced [2,21,27]. These studies confirmed the
e x i s t e n c eo f4 9f u n c t i o n a lV b genes within 24 different
Vb subgroups. Due to the heterogeneity, some of the 24
Vb subgroups consist of multiple subgroup genes. In
this study, we designed two primers annealing to each
of 22 different Vb subgroups (36 Vb genes) to quantify
expansion of T cell bearing specific Vb subgroups and
subgroup genes in response to SAgs.
One of the important factors that affect the validity of
qRT-PCR is the efficiency of primers. The primers used
in qRT-PCR should have uniform and high efficiency to
achieve a valid quantification. The efficiency and linear-
ity of primers could be assessed by analyzing the slope
and R
2 value of the standard curve, respectively. In the-
ory, the slope should be close to -3.32 with an optimal
efficiency when 10-fold serially diluted templates were
used. The average slope and R
2 of standard curves for
all primers used in qRT-PCR was -3.3764 ± 0.0245 and
0.99856 ± 0.000478, respectively. This suggests that all
0123456
16
18
20
22
24
26
28
30
32
34
36
38
C
T
Log
Copies
D
e
l
t
a
 
R
n
4
0
1
2
3
18 21 24 27 30 33 39 03 6 9 6 3 5 1 2 1
Cycle number
0.16
0.00
0.04
0.08
D
e
r
i
v
a
t
i
v
e
60 65 70 75 80 85 90 95
0.12
Temperature
0.16
0.00
0.04
0.08
D
e
r
i
v
a
t
i
v
e
0.12
0.20
0.24
60 65 70 75 80 85 90 95
Temperature
AB
CD
y=-3.38x+36.45
R2=0.9986
2.5 105 2.5
NTC
Threshold
Figure 1 The specificity, sensitivity, and reproducibility of qRT-PCR. The qRT-PCR was performed using a ten-fold dilution series (2.5 × 10
5
to 2.5 copies/reaction) of purified PCR product. Results shown are from a single representative experiment that was conducted three times. (A)
The qRT-PCR successfully amplified the ten-fold dilution series of template (2.5 × 10
5 to 2.5 copies/reaction; from left to right). The non-template
control (NTC) showed no amplification. The threshold was automatically set by Sequence Detector Systems version 1.2.2 software to synchronize
among experiments. The threshold cycle (CT) was determined by the cycle number at which the change in the fluorescence of the reporter dye
(delta Rn) crossed the threshold; (B) The standard curve was generated by plotting the CT vs the number of purified PCR product copies
(Log
copies). The slope and correlation coefficient (R
2) were -3.38 and 0.9986, respectively; (C) Melting curve analysis for the Vb1 subgroup consist
of single subgroup gene and showed a single peak at 78 oC; (D) Melting curve analysis for the Vb17 subgroup consisting of three subgroup
genes showed multiple peaks, consistent with the expected heterogeneity among amplified products.
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ciency and linearity.
The specificity of qRT-PCR using SYBR Green I plat-
form was often determined by analyzing melting curves.
In this study, the specificities of each primer set were
determined by analyzing melting curves and sequencing
amplified PCR products. Melting curve analysis and
sequencing amplified PCR products of reactions for, Cb
and Vb subgroups consisting of a single subgroup
showed a single peak and a single specific amplification.
As expected, some Vb subgroups comprised of multiple
subgroup genes (Vb7, 12, 13A, and 17) showed a corre-
sponding number of peaks. However, some Vb sub-
groups comprised of multiple subgroup genes (Vb5, 6,
8, 13B, and 21) showed only a single peak. The
sequence analysis of amplified PCR products for Vb5, 6,
8, 13B, and 21 subgroups revealed that multiple sub-
group genes were amplified. For example, the Vb6s u b -
group, consisting of 6 functional subgroup genes with >
87.9% sequence similarity to each other, showed a single
peak in melting curve analysis, though the sequence
analysis of amplified PCR product showed that all 6
functional subgroup genes were amplified. The resolu-
tion of these into a single peak probably due to a high
level nucleotide sequence similarity among subgroup
genes resulting in an identical meting temperature of
amplified gene fragments. The identity of all sequenced
PCR products matched with corresponding subgroups
Table 3 Standard curve slopes, Y axis intercepts and
correlation coefficients (R
2)
Primers Slope Y axis intercept Correlation coefficient (R
2)
Cb -3.38 36.45 0.9986
VB1 -3.39 36.54 0.9977
VB2 -3.36 36.38 0.9982
VB3 -3.41 36.57 0.9987
VB4 -3.37 36.62 0.9984
VB5 -3.35 36.33 0.9976
VB6 -3.40 36.53 0.9978
VB7 -3.36 36.43 0.9983
VB8 -3.37 36.40 0.9986
VB9 -3.38 36.49 0.9985
VB11 -3.41 36.52 0.9986
VB12 -3.42 36.53 0.9972
VB13A -3.34 36.34 0.9978
VB13B -3.41 36.54 0.9974
VB14 -3.36 36.33 0.9981
VB15 -3.35 36.44 0.9976
VB16 -3.37 36.44 0.9984
VB17 -3.39 36.53 0.9982
VB18 -3.35 36.44 0.9986
VB20 -3.33 36.39 0.9973
VB21 -3.36 36.38 0.9986
VB22 -3.39 36.47 0.9981
VB23 -3.37 36.43 0.9980
VB24 -3.41 36.53 0.9984
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Figure 2 Vb subgroup representation (%Vb) in unstimulated cultures and in cultures stimulated with a CD3-specific mAb.% V bs (mean
± S.E.M.) in cultures prior to stimulation or cultures of the same cell preparations after four days in the presence of the mAb. There was no
significant differences in %Vbs calculated for either condition (p < 0.05). Results shown are the mean ± S.E.M. of three sets of triplicates
combined from three experiments (n = 9).
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Page 6 of 9Figure 3 Distribution of %Vb in the cultures stimulated with SAgs. Non-adherent lymphocyte-enriched PBMCs were stimulated with SAgs
(final concentration at 5 μg/ml) for 4 days. The %Vbs were calculated and were presented as the mean ± S.E.M. Asterisks indicate a significant
increase in %Vb compared to cultures without stimuli (p < 0.05). Results shown are the means ± S.E.M. of three sets of triplicates combined from
three experiments (n = 9). A) Classic SEs and TSST-1. B) Novel SEs and SEls.
Table 4 Comparison of Vb specificity observed in this study with those in selected previous studies.
SAgs Vb specificity observed in this study Vb specificity observed in previous studiesa References
SEA Vb1, 5, 6, 7, 15, 16, 18, 21, 22, 24 Vb1, 5, 6, 7, 9, 16, 18, 21 [24]
SEB Vb3, 12, 13B
b, 14, 15, 17, 20 Vb1, 3, 6, 12, 13.2, 15, 17, 20 [11]
SEC1 Vb3, 12, 13B, 14, 15, 17, 20 Vb3, 12, 13.2, 14, 15, 17, 20 [12]
SED Vb1, 3, 5, 8, 9, 12, 14 Vb1, 5, 6, 7, 8, 12 [7,25]
SEE Vb5, 6, 8, 9, 13Ac, 16, 18 Vb5, 6, 8, 13.1, 18, 21 [11,24]
SEG Vb3, 12, 13A, 13B, 14, 15 Vb3, 12, 13, 14 [26]
SEI Vb1, 5, 6, 23 Vb1, 5, 6, 23 [26]
SElM Vb6, 8, 9, 18, 21 Vb6, 8, 9, 18, 21 [26]
SElN Vb7, 8, 9, 17 Vb9 [26]
SElO Vb5, 7 Vb5, 7, 22 [26]
TSST-1 Vb2V b2 [11]
aVb specificities were results from previous studies using semi-quantitative PCR or FACS methods.
bVb13B corresponds to Vb13.2 in previous studies.
cVb13A corresponds to Vb13.1 in previous studies.
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Page 7 of 9of Vb subgroups and revealed that 36 out of 49 func-
tional Vb subgroup genes were amplified. It suggests
that primers used in this study were highly specific to
targeted Vb subgroup.
In this study, we used various SAgs showing similar
and/or unique Vb specificities covering the entire reper-
toire of human Vb subgroups. The qRT-PCR showed
that every Vb subgroup was expanded in this study. As
s h o w ni nT a b l e4 ,t h eV b specificities of SAgs observed
in this study was very similar to those described in pre-
vious studies with minor variation [7,11,12,24-26]. In
this study, newly identified Vb specificities were
observed for some SAgs such as SEA (Vb15, 22, and
24), SEB (Vb 14), SED (Vb3, 9, and 14), SEE (Vb9a n d
16), SEG (Vb15), and SElN (Vb7, 8, and 17). Also, some
Vb previously reported specificities were not observed
for some SAgs such as SEB (Vb1a n d6 ) ,S E D( V b6a n d
7), SEE (Vb21), and SElO (Vb22). These discrepancies
m i g h tb ee x p l a i n e db yt h ed i f f e r e n c e si nt h er e p o s et o
SAgs among humans or differences in techniques (PCR,
flow cytometry), or the lack of reagents at the time of
previous studies. For example, the Vb specificity of
some SAgs in two previous studies was determined by
semi-quantitative PCR using primers specific to Vb1
through Vb20 [11,12]. This present study incorporated
primers specific to Vb21 through Vb24. However, it is
noteworthy that Vb subgroups most prominently
expanded by each SAg observed in this study were iden-
tical to those observed in previous studies.
Conclusion
In this report, we developed an assay to quantify the
expansion of human Vb subgroups using qRT-PCR. The
specificity and efficiency of the method were evaluated
by generating standard curves for each primer set. The
validity of the method was assessed by analyzing the Vb
specificity of various SAgs which combined, interact
with Vb repertoires covering all known Vb subgroups.
Our results demonstrate that the method established in
this study is accurate, sensitive, and highly reproducible.
This qRT-PCR method could also be used to character-
ize novel SAgs, to determine complete profiles of cur-
rently known SAgs, and to help understand the role of
T cells bearing specific Vbs in certain diseases such as
neoplastic expansion of large granular lymphocytes, T
cell non-Hodgkin’s lymphoma [28,29] as well as some
immune disorders associat e dw i t hS A g ss u c ha si m m u -
nosuppression, Kawasaki disease, and atopy [30-32].
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